| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019425 |
| Receipt No. | R000022466 |
| Scientific Title | Clinical Study of the Acceptability of Sanitary Napkin |
| Date of disclosure of the study information | 2015/12/01 |
| Last modified on | 2019/05/09 (Ver. 5) |
| Basic information | ||
| Public title | Clinical Study of the Acceptability of Sanitary Napkin | |
| Acronym | Clinical Study of the Acceptability of Sanitary Napkin | |
| Scientific Title | Clinical Study of the Acceptability of Sanitary Napkin | |
| Scientific Title:Acronym | Clinical Study of the Acceptability of Sanitary Napkin | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult females | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The objective of this study is to evaluate the acceptability of new sanitary napkin in subjects who experienced napkin dermatitis. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | This is an open, prospective study in order to evaluate the skin condition on genital area during the using of sanitary napkin and to evaluate skin's properties measurement (Skin hydration and skin pH) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Usage test of new sanitary napkin in subjects who experienced napkin dermatitis after the using of their usual sanitary napkin during their last menstrual cycle. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | -Healthy females
-Individuals who has experience of any symptoms of the itchiness or the offensive senses under the usage of feminine hygiene products during the last 3 menstrual period before screening. |
|||
| Key exclusion criteria | -Use of systemic medications or any medicated anti-pruritic or anti-fungal topical products to the genital area within 2 weeks of baseline measurements.
-Individuals with the symptom that is apparently necessary of doctor's care. -Pregnancy, nursing, or planning to become pregnant during the study as determined by the health questionnaire. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | PT Equilab International | ||||||
| Division name | Clinical research | ||||||
| Zip code | |||||||
| Address | JI. RS. Fatmawati Persil 33 Jakarta 12430 Indonesia | ||||||
| TEL | +62-21-7695513 | ||||||
| danang@equilab-int.com | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | PT Equilab International | ||||||
| Division name | Office | ||||||
| Zip code | |||||||
| Address | JI. RS. Fatmawati Persil 33 Jakarta 12430 Indonesia | ||||||
| TEL | +62-21-7695513 | ||||||
| Homepage URL | |||||||
| effi@equilab-int.com | |||||||
| Sponsor | |
| Institute | PT Equilab International |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | PT Equilab International |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022466 |